What Doctors Prescribe After Lipitor
Lipitor (atorvastatin), a statin for lowering cholesterol, is often followed by another statin if doses need adjustment, side effects occur, or better control is required. Crestor (rosuvastatin) is the most common next-step medication due to its higher potency at equivalent doses—10mg Crestor matches about 20mg Lipitor—and similar safety profile.[1]
Why Switch From Lipitor?
Patients switch for muscle pain (myalgia, affecting 5-10% on statins), inadequate LDL reduction, or cost. Guidelines from the American College of Cardiology recommend intensifying therapy with a more potent statin like Crestor before adding ezetimibe or PCSK9 inhibitors.[2] Lipitor's patent expired in 2011, so generics are cheap ($0.10/pill), but Crestor remains preferred for efficacy.
Crestor vs. Other Statin Alternatives
| Medication | Potency Relative to Lipitor 20mg | Common Reasons to Choose It | Generic Available? |
|------------|---------------------------------|-----------------------------|---------------------|
| Crestor (rosuvastatin) 10mg | Equivalent or higher | Stronger LDL drop (50-60%) | Yes (since 2016) |
| Lipitor higher dose (40-80mg) | 1.5-2x stronger | Stay on same drug | Yes |
| Zocor (simvastatin) 40mg | Weaker (30-40% drop) | Mild cases, cheaper | Yes |
| Pravachol (pravastatin) 40mg | Similar | Fewer drug interactions | Yes |
| Lescol (fluvastatin) | Weaker | Rare liver concerns | Yes |
Crestor leads U.S. prescriptions (15 million annually) post-Lipitor peak.[3]
Non-Statin Options If Statins Fail
For statin intolerance (e.g., rhabdomyolysis risk), doctors add or switch to:
- Ezetimibe (Zetia): Blocks cholesterol absorption; pairs with low-dose statin (LDL drop +15-20%).
- Bempedoic acid (Nexletol): Inhibits cholesterol synthesis upstream; for high-risk patients avoiding statins.
- PCSK9 inhibitors (Repatha, Praluent): Injections for familial hypercholesterolemia; expensive ($5,000+/year).
Patent and Cost Timeline
Lipitor's key patents ended November 2011, enabling generics and slashing prices from $3 to $0.10 per pill.[4] Crestor's main patent expired March 2016—check DrugPatentWatch.com for ongoing formulation patents.[4]
[1] NEJM: Statin Comparisons (2005)
[2] ACC/AHA Cholesterol Guidelines (2018)
[3] IQVIA Prescription Data (2023)
[4] DrugPatentWatch: Atorvastatin